DE-BUG-ER

Debugger (stylized as DE-BUG-ER) is a biotechnology company and Oxford University spin-out focused on revolutionizing the diagnosis of infectious diseases through ultra-rapid antibiotic susceptibility testing (AST). The company utilizes a proprietary single-molecule imaging platform that can detect bacterial growth and response to antibiotics within minutes, a process that traditionally takes 24 to 48 hours. Their primary focus is on point-of-care diagnostics for urinary tract infections (UTIs), enabling clinicians to prescribe the most effective antibiotic during the initial consultation. By providing actionable results in real-time, Debugger aims to combat the rise of antimicrobial resistance (AMR) and improve patient care in primary and secondary healthcare settings. The technology is based on years of research in biological physics and single-molecule fluorescence microscopy at the University of Oxford.